Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.
about
Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathyChanges in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice.Genetic determinants of myocardial dysfunction.Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathyIncreased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy.Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young.Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion studyNormal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy.In hypertrophic cardiomyopathy reduction of relative resting myocardial blood flow is related to late enhancement, T2-signal and LV wall thickness.Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.Determining the role of fibrosis in hypertrophic cardiomyopathy.Genetics and clinical destiny: improving care in hypertrophic cardiomyopathyAssociation of noninvasively measured left ventricular mechanics with in vitro muscle contractile performance: a prospective study in hypertrophic cardiomyopathy patients.Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.Genetics of inherited cardiomyopathy.Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations.The pathology of hypertrophic cardiomyopathy.Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosisCirculating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunctionContinuous and discontinuous propagation in heart muscle.Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophyLeft Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta) at the California National Primate Research Center (1992-2014)T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophyEchocardiographic Characterization of a Murine Model of Hypertrophic Obstructive Cardiomyopathy Induced by Cardiac-specific Overexpression of Epidermal Growth Factor Receptor 2.Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance.An endogenously produced fragment of cardiac myosin-binding protein C is pathogenic and can lead to heart failureAssociations between fibrocytes and postcontrast myocardial T1 times in hypertrophic cardiomyopathy.Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.Predictors of Atrial Fibrillation Risk in Hypertrophic Cardiomyopathy.Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy.Comparison of echocardiography with tissue Doppler imaging and magnetic resonance imaging with delayed enhancement in the assessment of children with hypertrophic cardiomyopathy.The role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophyFluid dynamic aspects of ejection in hypertrophic cardiomyopathy.Insights and challenges in hypertrophic cardiomyopathy, 2012.The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases.Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
P2860
Q26999424-58EACC67-BABE-40B5-8316-4E6F2AAF700FQ28593918-D7ED30BD-67CA-4863-A653-84AA63B25490Q30240839-4C1BA4CA-0900-4A05-8E7B-BBC4C86A387BQ33152812-A4EEEC84-F278-4C0B-BB66-ED5019900978Q33162387-FDF6E4BB-724D-49D7-A25C-F81814D21609Q33554999-7FD523B1-B487-4889-8DC4-1A893319E107Q34054904-B1B026AA-E588-4AF6-91A3-D6B8DB215C0DQ34091933-01272DF6-1FDE-43D0-9510-ED054917F44FQ34195823-DF582543-F5F0-4A36-BD84-9275CF84D7ACQ34364374-43B55937-3073-4850-BFD9-BDD1BCD4C167Q34629550-686C8E7F-4BB4-441E-B58E-4ADB4C242F7AQ34660599-08762A95-6A79-4A98-9878-2D9E8C686AF2Q34999606-31320951-6D72-48BC-9897-0D5E88EC3A17Q35115012-450E7A4B-9F62-4469-96CF-533BAA4535B7Q35584472-84E8EAEA-7411-42EB-874A-90D745E06D1DQ35721684-36D5C313-E12E-4960-AB39-B91CEF48FFE6Q35762855-E9F714EE-C9D9-46D6-9EAE-BC1F8AF7F1B7Q35771667-3124D408-EC6E-4917-A58E-CF19CC68E70CQ35771997-877FB27F-74B4-43FE-96AB-96930A501985Q36088154-C8EA9720-2AB8-4103-907C-96E50957DE6EQ36098649-1A66521D-3976-4409-B876-577A2425BC75Q36305091-D45DDC55-C889-4331-BD6E-ABB417149519Q36412765-60BE89B7-1466-4044-A0F0-8EF5D8178940Q36473119-72E8F91F-15AB-4657-AE0F-F7F0165ABE40Q36742782-2612BDB2-AEB1-4BFD-8E7D-3DBA87C954DFQ36781777-67CBC00D-CDB5-4F42-B84B-BC5286539AE1Q37160724-39EE2344-2A29-4BB7-98AB-DAB90B61540AQ37171740-59512743-F957-43B2-99E3-531322CE0790Q37318366-657832E3-F83C-406B-ACD6-DA3184A09C5EQ37328603-24EFE7BF-42E8-4DE8-B86E-BF76DEDE5FDDQ37328738-26E9D266-5BF9-4573-B5CA-35FF4BB13C4EQ37366263-E4A94677-FAA0-4B67-9ED4-C3185EFAFD5EQ37469007-A1FAC430-98B3-40B0-A7F4-6651C0DBD2EFQ37631139-577FAEDC-1BF3-4AC8-B6F5-98D60B3EA73FQ37675552-4176FD17-0AA3-49BA-A481-2BDA001D16E7Q37730496-972C02F4-B666-4BB5-BA64-C96403C3629BQ37937237-599E0FC7-7838-462A-920C-B96A3060CB93Q38046158-BAD66A58-938B-4767-9C0F-88C11CA79CB3Q38197734-1971599A-608E-4F84-A9A5-F84ABBD952A2Q38605392-2B977117-DA4E-4466-B755-7AACE06A2CAD
P2860
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Hypertrophic cardiomyopathy: t ...... sis, and small vessel disease.
@ast
Hypertrophic cardiomyopathy: t ...... sis, and small vessel disease.
@en
type
label
Hypertrophic cardiomyopathy: t ...... sis, and small vessel disease.
@ast
Hypertrophic cardiomyopathy: t ...... sis, and small vessel disease.
@en
prefLabel
Hypertrophic cardiomyopathy: t ...... sis, and small vessel disease.
@ast
Hypertrophic cardiomyopathy: t ...... sis, and small vessel disease.
@en
P2093
P2860
P356
P1433
P1476
Hypertrophic cardiomyopathy: t ...... sis, and small vessel disease.
@en
P2093
P2860
P304
P356
10.1136/HEART.84.5.476
P407
P577
2000-11-01T00:00:00Z